CLINICAL_TRIALS
trial_result
· 2026-03-02
Clinical Trial Update: Phase I Study Compound 451238 and Radiotherapy in Soft-tissue Sarcoma [Phase 1, Phase 2]
Summary
Phase I/II study of Compound 451238 with radiotherapy in soft-tissue sarcoma has completed; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Royal Marsden NHS Foundation Trust | Conditions: Soft-tissue Sarcoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2026-03-02